Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use) : The importance of routine mental health screening as a component of a comanagement model of care

Identifieur interne : 002681 ( Main/Exploration ); précédent : 002680; suivant : 002682

Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use) : The importance of routine mental health screening as a component of a comanagement model of care

Auteurs : Marian Fireman [États-Unis] ; David W. Indest [États-Unis] ; Aaron Blackwell [États-Unis] ; Ashlee J. Whitehead [États-Unis] ; Peter Hauser [États-Unis]

Source :

RBID : Pascal:05-0350402

Descripteurs français

English descriptors

Abstract

Background. Recent studies suggest that most patients with hepatitis C virus (HCV) infection commonly present to medical clinics with active psychiatric and substance use disorders. However, routine screening for these disorders is generally not done. Objectives. The purpose of our study was to assess prospectively the frequency of psychiatric and substance use disorders in patients presenting for initial assessment of a positive HCV antibody test result. Methods. A sample of 293 patients represented the majority of patients scheduled for their initial hepatology clinic visit at the Portland Veterans Affairs Medical Center between September 2002 and September 2003. The patient screening questionnaire, Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), and the Beck Depression Inventory (BDI-II) were administered to all patients. Results. At screening, 93% of the patients had a current or past history of at least 1 psychiatric disorder, and 73% had ≥2 disorders. The most common disorders included depression (81%), posttraumatic stress disorder (62%), any substance use disorder (58%), bipolar disorder (20%), and other psychotic disorders (17%). One hundred two patients (35%) had baseline BDI-II scores in the moderate-to-severe range of depression (>19), and 61 (21%) had AUDIT-C scores indicating current heavy alcohol use (≥4). Conclusions. Psychiatric and substance use disorders are highly prevalent among veterans with chronic hepatitis C. Thirty-five percent have significant symptoms of depression before the initiation of treatment with interferon (IFN). Routine screening for underlying psychiatric and substance use disorders and early treatment intervention before initiating antiviral therapy is essential to prevent worsening of depression and to optimize the outcome of treatment with IFN. Comanagement treatment models involving mental health care may expand the pool of patients eligible to receive treatment with IFN, as well as enhance treatment outcomes.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use) : The importance of routine mental health screening as a component of a comanagement model of care</title>
<author>
<name sortKey="Fireman, Marian" sort="Fireman, Marian" uniqKey="Fireman M" first="Marian" last="Fireman">Marian Fireman</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Indest, David W" sort="Indest, David W" uniqKey="Indest D" first="David W." last="Indest">David W. Indest</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blackwell, Aaron" sort="Blackwell, Aaron" uniqKey="Blackwell A" first="Aaron" last="Blackwell">Aaron Blackwell</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Whitehead, Ashlee J" sort="Whitehead, Ashlee J" uniqKey="Whitehead A" first="Ashlee J." last="Whitehead">Ashlee J. Whitehead</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hauser, Peter" sort="Hauser, Peter" uniqKey="Hauser P" first="Peter" last="Hauser">Peter Hauser</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>J.E.N.S. Laboratory, Portland Veterans Affairs Medical Center, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Department of Behavioral Neurosciences, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0350402</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0350402 INIST</idno>
<idno type="RBID">Pascal:05-0350402</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000244</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000065</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000164</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000164</idno>
<idno type="wicri:doubleKey">1058-4838:2005:Fireman M:addressing:tri:morbidity</idno>
<idno type="wicri:Area/Main/Merge">002685</idno>
<idno type="wicri:Area/Main/Curation">002681</idno>
<idno type="wicri:Area/Main/Exploration">002681</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use) : The importance of routine mental health screening as a component of a comanagement model of care</title>
<author>
<name sortKey="Fireman, Marian" sort="Fireman, Marian" uniqKey="Fireman M" first="Marian" last="Fireman">Marian Fireman</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Indest, David W" sort="Indest, David W" uniqKey="Indest D" first="David W." last="Indest">David W. Indest</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blackwell, Aaron" sort="Blackwell, Aaron" uniqKey="Blackwell A" first="Aaron" last="Blackwell">Aaron Blackwell</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Whitehead, Ashlee J" sort="Whitehead, Ashlee J" uniqKey="Whitehead A" first="Ashlee J." last="Whitehead">Ashlee J. Whitehead</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hauser, Peter" sort="Hauser, Peter" uniqKey="Hauser P" first="Peter" last="Hauser">Peter Hauser</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>J.E.N.S. Laboratory, Portland Veterans Affairs Medical Center, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Department of Behavioral Neurosciences, Oregon Health and Sciences University</s1>
<s2>Portland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Portland</settlement>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alcoholism</term>
<term>Audit</term>
<term>Bipolar disorder</term>
<term>Depression</term>
<term>Drug addiction</term>
<term>Human</term>
<term>Medical screening</term>
<term>Mental disorder</term>
<term>Morbidity</term>
<term>Posttraumatic stress disorder</term>
<term>Posttraumatic syndrome</term>
<term>Prevention</term>
<term>Prognosis</term>
<term>Questionnaire</term>
<term>Stress</term>
<term>Substance abuse</term>
<term>Symptomatology</term>
<term>Treatment</term>
<term>Viral hepatitis C</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Hépatite virale C</term>
<term>Toxicomanie</term>
<term>Alcoolisme</term>
<term>Morbidité</term>
<term>Trouble psychiatrique</term>
<term>Dépistage</term>
<term>Homme</term>
<term>Questionnaire</term>
<term>Audit</term>
<term>Etat dépressif</term>
<term>Posttraumatisme syndrome</term>
<term>Stress</term>
<term>Trouble bipolaire</term>
<term>Symptomatologie</term>
<term>Traitement</term>
<term>Prévention</term>
<term>Pronostic</term>
<term>Forme grave</term>
<term>Abus de substance</term>
<term>Etat de stress posttraumatique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Toxicomanie</term>
<term>Alcoolisme</term>
<term>Homme</term>
<term>Audit</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background. Recent studies suggest that most patients with hepatitis C virus (HCV) infection commonly present to medical clinics with active psychiatric and substance use disorders. However, routine screening for these disorders is generally not done. Objectives. The purpose of our study was to assess prospectively the frequency of psychiatric and substance use disorders in patients presenting for initial assessment of a positive HCV antibody test result. Methods. A sample of 293 patients represented the majority of patients scheduled for their initial hepatology clinic visit at the Portland Veterans Affairs Medical Center between September 2002 and September 2003. The patient screening questionnaire, Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), and the Beck Depression Inventory (BDI-II) were administered to all patients. Results. At screening, 93% of the patients had a current or past history of at least 1 psychiatric disorder, and 73% had ≥2 disorders. The most common disorders included depression (81%), posttraumatic stress disorder (62%), any substance use disorder (58%), bipolar disorder (20%), and other psychotic disorders (17%). One hundred two patients (35%) had baseline BDI-II scores in the moderate-to-severe range of depression (>19), and 61 (21%) had AUDIT-C scores indicating current heavy alcohol use (≥4). Conclusions. Psychiatric and substance use disorders are highly prevalent among veterans with chronic hepatitis C. Thirty-five percent have significant symptoms of depression before the initiation of treatment with interferon (IFN). Routine screening for underlying psychiatric and substance use disorders and early treatment intervention before initiating antiviral therapy is essential to prevent worsening of depression and to optimize the outcome of treatment with IFN. Comanagement treatment models involving mental health care may expand the pool of patients eligible to receive treatment with IFN, as well as enhance treatment outcomes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Oregon</li>
</region>
<settlement>
<li>Portland</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Oregon">
<name sortKey="Fireman, Marian" sort="Fireman, Marian" uniqKey="Fireman M" first="Marian" last="Fireman">Marian Fireman</name>
</region>
<name sortKey="Blackwell, Aaron" sort="Blackwell, Aaron" uniqKey="Blackwell A" first="Aaron" last="Blackwell">Aaron Blackwell</name>
<name sortKey="Fireman, Marian" sort="Fireman, Marian" uniqKey="Fireman M" first="Marian" last="Fireman">Marian Fireman</name>
<name sortKey="Hauser, Peter" sort="Hauser, Peter" uniqKey="Hauser P" first="Peter" last="Hauser">Peter Hauser</name>
<name sortKey="Hauser, Peter" sort="Hauser, Peter" uniqKey="Hauser P" first="Peter" last="Hauser">Peter Hauser</name>
<name sortKey="Hauser, Peter" sort="Hauser, Peter" uniqKey="Hauser P" first="Peter" last="Hauser">Peter Hauser</name>
<name sortKey="Hauser, Peter" sort="Hauser, Peter" uniqKey="Hauser P" first="Peter" last="Hauser">Peter Hauser</name>
<name sortKey="Indest, David W" sort="Indest, David W" uniqKey="Indest D" first="David W." last="Indest">David W. Indest</name>
<name sortKey="Indest, David W" sort="Indest, David W" uniqKey="Indest D" first="David W." last="Indest">David W. Indest</name>
<name sortKey="Whitehead, Ashlee J" sort="Whitehead, Ashlee J" uniqKey="Whitehead A" first="Ashlee J." last="Whitehead">Ashlee J. Whitehead</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002681 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002681 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0350402
   |texte=   Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use) : The importance of routine mental health screening as a component of a comanagement model of care
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021